← FDA DRUG APPROVALS

FDA ANDA · ANDA040586

PRIMIDONE

Sponsor: OXFORD PHARMS

APPLICATION
ANDA040586
TYPE
ANDA
ORIGINAL APPROVAL
2005-02-24
LATEST ACTION
2012-06-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

PRIMIDONEPrescription
PRIMIDONE 50MG · TABLET · ORAL
PRIMIDONEPrescription
PRIMIDONE 250MG · TABLET · ORAL

Approval history

2012-06-25Labeling · Supplement 9 · standardAP
2011-03-29Labeling · Supplement 6AP
2010-05-20Labeling · Supplement 4AP
2006-02-06Labeling · Supplement 1AP
2005-02-24OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →